Sample Size, Error Rates and Optimality Considerations for Phase II Clinical Trials
So far, most Phase II trials have been designed and analysed under a frequentist framework. Under this framework, a trial is designed so that the overall Type I and Type II errors of the trial are controlled at some desired levels. Recently, a number of articles have advocated the use of Bayesian de...
Saved in:
Main Authors: | Wang, Y. G., Leung, Denis H. Y., Li, M., TAN, S. B. |
---|---|
Format: | text |
Language: | English |
Published: |
Institutional Knowledge at Singapore Management University
2005
|
Subjects: | |
Online Access: | https://ink.library.smu.edu.sg/soe_research/418 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Singapore Management University |
Language: | English |
Similar Items
-
Sample size, error rates and effects of prior-misspecifications in phase II clinical trials
by: LONG YU
Published: (2011) -
Sample size estimation with missing values on clinical trials
by: Zhang, Mengyang
Published: (2019) -
A Bayesian Decision Approach for Sample Size Determination in Phase II Trials
by: LEUNG, Denis H. Y., et al.
Published: (2001) -
R Package for Binomial Tree of Cox, Ingersoll, and Ross (CIR) Interest Rate
by: Yunita Wulan Sari, Yunita Wulan Sari, et al.
Published: (2014) -
INFERENSI BAYESIAN DALAM WAVELET SHRINKAGE
by: Wahyan, Wahyan, et al.
Published: (2003)